XYLOCAINE(R) -MPF (LIDOCAINE HCI AND EPINEPHRINE INJECTION, USP) WITH EPINEPHRINE 1:200,000 2% 200mg per 10mL (20mg per mL) 10mL VIAL. Packaging: 1/ea

Lidocaine HCl Inj., USP, 2% 100 mg per 5 mL 100 mg Luer-Jet Syr. Packaging: 1/ea

1% Lidocaine HCl Injection, USP 50mg/5mL (10mg/mL) 5mL Ansyr Syr. Packaging: 1/ea

Lidocaine hydrochloride administered intravenously is specifically indicated in the acute management of (1)ventricular arrhythmias occurring during cardiac manipulations, such as cardiac surgery and (2) life-threatening arrhythmias which are ventricular in origin, such as occur during acute myocardial infarction. Packaging: 1/ea

Lidocaine hydrochloride administered intravenously is specifically indicated in the acute management of (1)ventricular arrhythmias occurring during cardiac manipulations, such as cardiac surgery and (2) life-threatening arrhythmias which are ventricular in origin, such as occur during acute myocardial infarction. Packaging: 1/ea

Medication type: anticonvulsant. A sterile, concentrated solution of Magnesium Sulfate USP, indicated for immediate control of various conditions including convulsions. Medical license required to purchase. Packaging: 1/ea

Magnesium Sulfate Injection, USP 50% 1gram per 2mL (500mg per mL) 2mL vial. Packaging: 1/ea

Metoclopramide Injection, USP 10 mg/2 mL (5mg/mL) 2mL Syr. Packaging: 1/ea

Diabetic Gastroparesis (Diabetic Gastric Stasis). Metoclopramide is indicated for the relief of symptoms associated with acute and recurrent diabetic gastric stasis. The Prevention of Nausea and Vomiting Associated with Emetogenic CancerChemotherapy. Metoclopramide Injection, USP is indicated for the prophylaxis of vomiting associated with emetogenic cancer chemotherapy. The Prevention of Postoperative Nausea and Vomiting. Metoclopramide Injection, USP is indicated for the prophylaxis ofpostoperative nausea and vomiting in those circumstances where nasogastric suction is undesirable. Small Bowel Intubation. Metoclopramide Injection, USP may be used to facilitate small bowel intubation in adults and pediatric patients in whom the tube does not pass the pylorus with conventional maneuvers. Radiological Examination. Metoclopramide Injection, USP may be used to stimulate gastric emptying and intestinal transit of barium in cases where delayed emptying interferes with radiological examinationof the stomach and/or small intestine. Packaging: 1/ea

Metoprolol Tartrate Injection, USP 5 mg/5 mL (1mg/mL) 5 mL Vial. Packaging: 1/ea

Nalbuphine HCl Inj. 10mg/mL 10mL vial. Packaging: 1/ea

Naloxone Hydrochloride Injection, USP 0.4mg/mL 10mL vial. Packaging: 1/ea

USP 0.4mg/ml Carpuject®. Medication type: antidote. Naloxone is an opioid antagonist used to reverse narcotic overdose. Brand name: Narcan. Medical license required to purchase. Packaging: 1/ea

2 mL pre-filled syringe. Medication type: antidote. Naloxone is an opioid antagonist used to reverse narcotic overdose. Brand name: Narcan. Medical license or doctor's prescription required to purchase. Packaging: 1/ea

Nesacaine(R) (Chloroprocaine HCl Injection, USP) 1% (300mg per 30mL) (10mg per mL) 30mL vial. Packaging: 1/ea

Nesacaine(R) (Chloroprocaine HCl Injection, USP) 2% (600mg per 30mL) (20mg per mL) 30mL vial. Packaging: 1/ea

Nesacaine(R) -MPF (Chloroprocaine HCl Injection, USP) 2% (400mg per 20mL) (20mg per mL) 20mL vial. Packaging: 1/ea

Nexterone (Amiodarone HCl) Premixed Injection 360mg/200mL (1.8mg/mL) 200mL Bag. Packaging: 1/ea

Nicardipine Hydrochloride Injection 25mg/10mL (2.5 mg/mL) 10mL Vial. Packaging: 1/ea

Nitroglycerin Injection, USP 50mg/10mL (5mg/mL) 10mL Vial. Packaging: 1/ea

Nitroglycerin Sublingual Tablets, USP 0.4mg/Tab 25 Tablets. Packaging: 1/ea

Norepinephrine Bitartrate Injection, USP 4mg/4mL (1mg/mL) 4mL Vial. Packaging: 1/ea

Phenylephrine HCI Injection, USP 10mg/mL 1mL Vial. Packaging: 1/ea

Phenytoin Sodium Injection, USP 100mg/2mL (50mg/mL) Vial. Packaging: 1/ea

Physostigmine Salicylate Injection (1mg/mL) 2mL Ampule. Packaging: 1/ea